Not business as usual: Engaging the corporate sector in India's TB elimination efforts.

Autor: Carwile M; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA., Cintron C; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA., Jain K; Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India., Buonomo G; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA., Oliver M; Ending Workplace TB Program, Cambridge, UK., Dauphinais M; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA., Narasimhan PB; Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India., Prakash Babu S; Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India., Sarkar S; Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India., Locks L; Department of Health Sciences, Boston University: College of Health & Rehabilitation Sciences: Sargent College, Boston, MA, USA.; Department of Global Health, Boston University School of Public Health, Boston, MA, USA., Kulatilaka N; Susilo Institute for Ethics in a Global Economy, Boston University Questrom School of Business, Boston, MA, USA., Hochberg N; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.; Boston Medical Center, Boston, MA, USA., Lakshminarayanan S; Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India., Sinha P; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.; Boston Medical Center, Boston, MA, USA.
Jazyk: angličtina
Zdroj: Global public health [Glob Public Health] 2023 Jan; Vol. 18 (1), pp. 2120405.
DOI: 10.1080/17441692.2023.2216321
Abstrakt: India has the highest global burden of tuberculosis (TB), accounting for a quarter of the worldwide TB disease incidence. Given the magnitude of India's epidemic, TB has enormous economic implications. Indeed, the majority of individuals with TB disease are in their prime years of economic productivity. Absenteeism and employee turnover due to TB have economic ramifications for employers. Furthermore, TB can easily spread in the workplace and compound the economic impact. Employers who fund workplace, community, or national TB initiatives stand to gain directly and also enjoy reputational benefits, which are important in the era of socially conscious investing. Corporate social responsibility laws in India and tax incentives can be leveraged to bring the logistical networks, reach, and innovative spirit of the private sector to bear on India's formidable TB epidemic. In this perspective piece, we explore the economic impacts of TB; opportunities for and benefits from businesses contributing to TB elimination efforts; and strategies to enlist India's corporate sector in the fight against TB.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje